Aguado, T., Carracedo, A., Julien, B., Velasco, G., Milman, G., et.al. (2007). Cannabinoids
induce glioma stem-like cell differentiation and inhibit gliomagenesis. J Biol Chem.,
282(9), 6854-62.
Bari, M., Battista, N., Fezza, F., Finazzi-Agr�, A., & Maccarrone M. (2005).
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells.
Implications for anandamide-induced apoptosis. J Biol Chem., 280(13),
12212-20.
Bifulco, M., Malfitano, A.M., Pisanti, S., & Laezza, C. (2008). Endocannabinoids
in endocrine and related tumours. Endocr. Relat. Cancer, 15(2), 391-408.
Bifulco, M., Laezza, C., Pisanti, S., & Gazzerro, P. (2006). Cannabinoids and
cancer: pros and cons of an antitumour strategy. Br J Pharmacol., 148(2),
123-35.
Bifulco, M., Laezza, C., Valenti, M., Ligresti, A., Portella, G., et.al. (2004).
A new strategy to block tumor growth by inhibiting endocannabinoid inactivation.
FASEB J., 18(13), 1606-8.
Bl�zquez, C., Salazar, M., Carracedo, A., Lorente, M., Egia, A., et.al. (2008).
Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2
expression. Cancer Res., 68(6), 1945-52.
Bl�zquez, C., Carracedo, A., Barrado, L., Real, P.J., Fern�ndez-Luna, J.L., et.al.
(2006). Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB
J., 20(14), 2633-5.
Bl�zquez, C., Gonz�lez-Feria, L., Alvarez, L., Haro, A., Casanova, M.L., et.al.
(2004). Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.
Cancer Res., 64(16), 5617-23.
Bl�zquez, C., Casanova, M.L., Planas, A., G�mez Del Pulgar, T., Villanueva, C.,
et.al. (2003). Inhibition of tumor angiogenesis by cannabinoids. FASEB J.,
17(3), 529-31.
Caffarel MM, Sarri� D, Palacios J, Guzm�n M, & S�nchez C. (2006). Delta9-tetrahydrocannabinol
inhibits cell cycle progression in human breast cancer cells through Cdc2 regulation.
Cancer Res., 66(13), 6615-21.
Carracedo, A., Gironella, M., Lorente, M., Garcia, S., Guzm�n, M., et.al. (2006).
Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum
stress-related genes. Cancer Res., 66(13), 6748-55.
Contassot, E., Tenan, M., Schnu�riger, V., Pelte, M.-F., & Dietrich, P.-Y. (2004).
Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly
expressed vanilloid receptor-1. Gynecologic Oncology, 93(1), 182�188.
Curran, N.M., Griffin, B.D., O'Toole, D., Brady, K.J., Fitzgerald, S.N., et.al.
(2005). The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling
pathway in human astrocytes in a cannabinoid receptor-independent manner. J Biol
Chem., 280(43), 35797-806.
Casanova, M.L., Bl�zquez, C., Mart�nez-Palacio, J., Villanueva, C., Fern�ndez-Ace�ero,
M.J., at.el. (2003). Inhibition of skin tumor growth and angiogenesis in vivo by
activation of cannabinoid receptors. J Clin Invest., 111(1), 43-50.
Gustafsson, K., Christensson, B., Sander, B., & Flygare, J. (2006). Cannabinoid
receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated
with ceramide accumulation and p38 activation in mantle cell lymphoma. Mol Pharmacol.,
70(5), 1612-20.
Guzm�n, M., Duarte, M.J., Bl�zquez, C., Ravina, J., Rosa, M.C., et.al. (2006). A
pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma
multiforme. Br J Cancer., 95(2), 197-203.
Hinz, B., Ramer, R., Eichele, K., Weinzierl, U., & Brune, K. (2004). Up-regulation
of cyclooxygenase-2 expression is involved in R(+)-methanandamide-induced apoptotic
death of human neuroglioma cells. Mol Pharmacol., 66(6), 1643-51.
Jia, W., Hegde, V.L., Singh, N.P., Sisco, D., Grant, S., et.al. (2006). Delta9-tetrahydrocannabinol-induced
apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.
Mol Cancer Res., 4(8), 549-62.
Klein, T.W., Newton, C., Larsen, K., Lu, L., Perkins, I., et.al. (2003). The cannabinoid
system and immune modulation. J Leukoc Biol., 74(4), 486-96.
Kogan, N.M., Schlesinger, M., Peters, M., Marincheva, G., Beeri, R., et.al. (2007).
A cannabinoid anticancer quinone, HU-331, is more potent and less cardiotoxic than
doxorubicin: a comparative in vivo study. J Pharmacol Exp Ther., 322(2),
646-53.
Kogan, N.M., Schlesinger, M., Priel, E., Rabinowitz, R., Berenshtein, E., et.al.
(2007). HU-331, a novel cannabinoid-based anticancer topoisomerase II inhibitor.
Mol Cancer Ther., 6(1), 173-83.
Ligresti, A., Moriello, A.S., Starowicz, K., Matias, I., Pisanti, S., et.al. (2006).
Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol
on human breast carcinoma. J Pharmacol Exp Ther., 318(3), 1375-87.
Maccarrone, M. & Finazzi-Agro�, A. (2003). The endocannabinoid system, anandamide
and the regulation of mammalian cell apoptosis. Cell Death and Differentiation,
10(9), 946�955.
Massi, P., Vaccani, A., Ceruti, S., Colombo, A., Abbracchio, M.P., et.al. (2004).
Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma
cell lines. J Pharmacol Exp Ther., 308(3), 838-45.
McAllister, S.D., Christian, R.T., Horowitz, M.P., Garcia, A., & Desprez, P.Y.
(2007). Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast
cancer cells. Mol Cancer Ther., 6(11), 2921-7.
McKallip, R.J., Jia, W., Schlomer, J., Warren, J.W., Nagarkatti, P.S., et.al. (2006).
Cannabidiol-induced apoptosis in human leukemia cells: A novel role of cannabidiol
in the regulation of p22phox and Nox4 expression. Mol Pharmacol.,70(3),
897-908.
Melamede, R. (2005). Cannabis and tobacco smoke are not equally carcinogenic. Harm
Reduct J., 2:21, doi:10.1186/1477-7517-2-21.
Michalski, C.W., Oti, F.E., Erkan, M., Sauliunaite, D., Bergmann, F., et.al. (2008).
Cannabinoids in pancreatic cancer: correlation with survival and pain. Int J Cancer.,
122(4), 742-50.
Munson, A.E., Harris, L.S., Friedman, M.A., Dewey, W.L., & Carchman, R.A. (1975).
Antineoplastic activity of cannabinoids. Journal of the National Cancer Institute,
55(3), 597-602.
Nithipatikom, K., Endsley, M.P., Isbell, M.A., Falck, J.R., Iwamoto, Y., et.al.
(2004). 2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate
cancer cell invasion. Cancer Res., 64(24), 8826-30.
Patsos, H.A., Hicks, D.J., Dobson, R.R., Greenhough, A., Woodman, N., et.al. (2005).
The endogenous cannabinoid, anandamide, induces cell death in colorectal carcinoma
cells: a possible role for cyclooxygenase 2. Gut, 54(12), 1741-50.
Portella, G., Laezza, C., Laccetti, P., De Petrocellis, L., Di Marzo, V., et.al.
(2003). Inhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth
and metastatic spreading: actions on signals involved in angiogenesis and metastasis.
FASEB J., 17(12), 1771-3.
Ramer, R. & Hinz, B. (2008). Inhibition of cancer cell invasion by cannabinoids
via increased expression of tissue inhibitor of matrix metalloproteinases-1. J Natl
Cancer Inst., 100(1), 59-69.
Rosenblatt, K.A., Daling, J.R., Chen, C., Sherman, K.J., & Schwartz, S.M. (2004).
Marijuana Use and Risk of Oral Squamous Cell Carcinoma. Cancer Res., 64(11),
4049�4054.
Rudolph, M.I., Boza, Y., Yefi, R., Luza, S., Andrews, E., et.al. (2008). The influence
of mast cell mediators on migration of SW756 cervical carcinoma cells. J Pharmacol
Sci., 106(2), 208-18.
Sarfaraz, S., Adhami, V.M., Syed, D.N., Afaq, F., & Mukhtar, H. (2008). Cannabinoids
for cancer treatment: progress and promise. Cancer Res., 68(2), 339-42.
Sarfaraz, S., Afaq, F., Adhami, V.M., Malik, A., & Mukhtar, H. (2006). Cannabinoid
receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds
through sustained activation of ERK1/2 leading to G1 cell cycle arrest. J Biol Chem.,
281(51), 39480-91.
Sarfaraz, S., Afaq, F., Adhami, V.M., & Mukhtar, H. (2005). Cannabinoid receptor
as a novel target for the treatment of prostate cancer. Cancer Res., 65(5),
1635-41.
Schenning, M., van Tiel, C.M., van Manen, D., Stam, J.C., Barend M., et.al. (2004).
Phosphatidylinositol transfer protein regulates growth and apoptosis of NIH3T3 cells:
involvement of a cannabinoid 1-like receptor. J. Lipid Res., 45(8), 1555�1564.
Vaccani, A., Massi, P., Colombo, A., Rubino, T., & Parolaro, D. (2005). Cannabidiol
inhibits human glioma cell migration through a cannabinoid receptor-independent
mechanism. Br J Pharmacol., 144(8), 1032-6.
Wang, D., Wang, H., Ning, W., Backlund, M.G., Dey, S.K., et.al. (2008). Loss of
cannabinoid receptor 1 accelerates intestinal tumor growth.Cancer Res.,
68(15), 6468-76.
Ware, M.A., Daeninck, P., & Maida, V. (2008). A review of nabilone in the treatment
of chemotherapy-induced nausea and vomiting. Ther Clin Risk Manag., 4(1),
99-107.